The Affiliated Companies program, operational since March 2016, is composed of 39 companies, such as service and product providers, that are developing tools to advance therapeutic needs. The Institute will coordinate interactions between affiliated companies and academic, pharmaceutical or biotechnology partners, with the aim of making a cohesive therapeutically minded community.